318 related articles for article (PubMed ID: 22021337)
1. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation.
Madala SK; Schmidt S; Davidson C; Ikegami M; Wert S; Hardie WD
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):380-8. PubMed ID: 22021337
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis.
Korfhagen TR; Le Cras TD; Davidson CR; Schmidt SM; Ikegami M; Whitsett JA; Hardie WD
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):562-72. PubMed ID: 19244201
[TBL] [Abstract][Full Text] [Related]
3. MEK inhibition suppresses the development of lung fibrosis in the bleomycin model.
Galuppo M; Esposito E; Mazzon E; Di Paola R; Paterniti I; Impellizzeri D; Cuzzocrea S
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):21-37. PubMed ID: 21533992
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
5. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling.
Tourkina E; Gooz P; Pannu J; Bonner M; Scholz D; Hacker S; Silver RM; Trojanowska M; Hoffman S
J Biol Chem; 2005 Apr; 280(14):13879-87. PubMed ID: 15691837
[TBL] [Abstract][Full Text] [Related]
7. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.
Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N
Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792
[TBL] [Abstract][Full Text] [Related]
9. Amphiregulin, an epidermal growth factor receptor ligand, plays an essential role in the pathogenesis of transforming growth factor-β-induced pulmonary fibrosis.
Zhou Y; Lee JY; Lee CM; Cho WK; Kang MJ; Koff JL; Yoon PO; Chae J; Park HO; Elias JA; Lee CG
J Biol Chem; 2012 Dec; 287(50):41991-2000. PubMed ID: 23086930
[TBL] [Abstract][Full Text] [Related]
10. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
11. Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis.
García-Alvarez J; Ramirez R; Checa M; Nuttall RK; Sampieri CL; Edwards DR; Selman M; Pardo A
Exp Lung Res; 2006 May; 32(5):201-14. PubMed ID: 16908447
[TBL] [Abstract][Full Text] [Related]
12. Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.
Madala SK; Sontake V; Edukulla R; Davidson CR; Schmidt S; Hardie WD
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):792-803. PubMed ID: 27438654
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
[TBL] [Abstract][Full Text] [Related]
15. Regulation of matrix contraction in chronic venous disease.
Pappas PJ; Lal BK; Ohara N; Saito S; Zapiach L; Durán WN
Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):518-29. PubMed ID: 19560950
[TBL] [Abstract][Full Text] [Related]
16. Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade.
Kang YH; Yang IJ; Shin HM
J Nat Med; 2012 Jan; 66(1):177-84. PubMed ID: 21833774
[TBL] [Abstract][Full Text] [Related]
17. Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis.
Madala SK; Edukulla R; Phatak M; Schmidt S; Davidson C; Acciani TH; Korfhagen TR; Medvedovic M; Lecras TD; Wagner K; Hardie WD
PLoS One; 2014; 9(1):e86536. PubMed ID: 24475138
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoke exposure reveals a novel role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR.
Xu X; Balsiger R; Tyrrell J; Boyaka PN; Tarran R; Cormet-Boyaka E
Biochim Biophys Acta; 2015 Jun; 1850(6):1224-32. PubMed ID: 25697727
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
20. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
